Merus

Developer of antibody-based drugs for cancer treatment

placeUtrecht, Utrecht, Netherlands calendar_todayFounded 2003 groups221 employees language merus.nl

Registered entities

Innovation

77 patent families (33 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace steady. Cited 38,373 times.

YearFilings
20153
20166
201712
201815
201917
202029
202129
202234
202341
202441
202543
20268

Social engagement

Social engagement: 17.3K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

17 investors on record.

Investor typeCountShare
Venture capital953%
Private equity318%
Other / undisclosed529%

Recent activity

11 Dec 2025
Recognition
18 Nov 2025
Partnership
Halozyme
Coming soon